ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements with these filters
Equity shareholders of Torrent Pharmaceuticals Limited approved the Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited. The resolution was passed with the requisite majority through remote e-voting and e-voting at the NCLT-convened meeting held on April 28, 2026.
Torrent Pharmaceuticals Limited submitted details of four listed Non-Convertible Debentures (NCDs) totalling ₹11,000 Crore issued via private placement. The company also confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025. This filing maintains regulatory compliance regarding debt security disclosures for the half-year ended March 31, 2026.
Torrent Pharmaceuticals Limited received a clean report from the USFDA for its Bileshwarpura (Oncology) facility. The inspection, conducted from April 6 to April 10, 2026, concluded with zero observations. This successful regulatory outcome confirms compliance with international manufacturing standards for the oncology site.
Torrent Pharmaceuticals Limited confirmed the full utilization of proceeds from its issued Commercial Papers for the quarter ending March 31, 2026. This filing adheres to SEBI Master Circular requirements regarding debt instruments.
Torrent Pharmaceuticals Ltd reported net profit of ₹635 Cr (+26.2% YoY) for Q3 FY26.